// App-Quantinova.ai

: Intravascular Cells and Circulating Microparticles Induce Procoagulant Activity Via Phosphatidylserine Exposure in Venous Thromboembolism and Contribute to Altered Plasma Fibrin Clot Properties

Researchers

Presenter

  • Yan Kou

Principal Investigators

  • Lili Zou

  • Hui Liang

  • Li Hou

  • Tao Li

  • Yan Zhang

  • Baorong LI

  • Yingmiao LIU

  • Cong Zhang

  • Ruipeng Liu

  • Xinyi Zhao

  • Ying Wang

  • Jiaqi Jin

  • Yayan Bi

  • Jialan Shi

  • Junjie Kou

Medical Centers

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Second Affiliated Hospital of Dalian Medical University, Dalian, China

  • Second Affiliated Hospital of Dalian Medical University, Dalian, China

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Surgery, Brigham and Women's Hospital, VA Boston Healthcare System and Harvard Medical School, Boston, MA

Locations

  • China

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Cluster of Differentiation 14

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 31

  • Matrix metalloproteinase

Drug/Treatment

  • Phosphatidylserine

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved